Charlotte

Leadership Team and Participants

Primary Contact

Maritza Izquierdo
Fresenius Health Partners
maritza.izquierdo@fmc-na.com
(512) 277-6565

Maria Radonova
Integrated Care Group,
Fresenius Health Partners
Actuary

Clinical Leadership Contact

Terry Ketchersid, MD
Integrated Care Group,
Fresenius Medical Care North America
terry.ketchersid@fmc-na.com
(512) 277-6565

Maureen Bernacki
Integrated Care Group
Finance

Facilities

BIO-MEDICAL APPLICATIONS OF NORTH CAROLINA, INC.
BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC.
INDEPENDENT NEPHROLOGY SERVICES, LLC

Participants

Metrolina Nephrology Associates, PA
Adit Mahale
Andrew Norris
Andrew O'Connor
Angela Lamkin
Anjali Singla
Anna Marshall
Anna Pasour
Brandie Buckingham
Brittney McGuirt
Carl Fisher
Charles Stoddard
Chris Fotiadis
Cynthia Shierts
Daniel Tierney
Dianne Audette
Donald Berling
Douglas Nigbor
Emily Simoneau
Ernest Johnson
Gary Schreck
Gautam Phadke
Gene Radford
George Hart
Gregory Merten
Holly Garner
Jane Bycroft
Jeffrey Nielsen
Joel Bruce
John Gerig
Jonathan Planer
Julie Peterson
Katerina Jones
Kendall Schuyler
Kevin Lowe
Kimberly Yates
Laura Reevey
Leah Smith
Lynn Allen
Matthew Elliott
Mehul Patel
Melissa Bevins
Melissa Hodapp
Michael Etomi
Mona Shaban
Nancy Gritter
Nancy Marvin
Nathan Woolwine
Paul Blake
Paul Cheifetz
Peale Chuang
Pranab Acharya
Rebecca Morton
Shannon Lang
Sonal Patel
Sonni Sly
Suzanne Katsanos
Thomas Smarz
Tina Grue
Tina Kelly
Todd Griffith
Trenia Keys
Verachai Lohavichan
Vidhi Patel
Vivek Sanghani

Kidney Care Choices Model Implementation Period Notice of Waiver

The Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services’ Office of Inspector General have provided certain waivers of federal fraud and abuse laws in connection with participation during the Implementation Period in the Comprehensive Kidney Care Contracting (“CKCC”) Option of the Kidney Carse Choices (“KCC”) Model (“KCC Implementation Period Waivers”). In accordance with such Waivers, the KCE provides notice that the Implementation Period KCE Activities arrangement described below is being provided under the protection of the KCC Implementation Period Waivers.

Implementation Period KCE Activities: The Board of Managers of Charlotte Kidney Care Entity, LLC (the “CE”) has duly authorized the following arrangement and has made a bona fide determination that this arrangement is reasonably related to the performance of KCE Activities during the Implementation Period because the arrangement is in preparation for and will promote the future accountability for the quality, cost, and overall care for KCE Beneficiaries. As of October 19, 2021, the KCE has engaged BIO-MEDICAL APPLICATIONS OF SOUTH CAROLINA, INC., a KCE Preferred Provider, to provide certain services and items in preparation for the start of the Performance Year. Such services and items include care coordination and management services, education related to performance under a risked-based financial arrangement, and information technology to improve care processes and to prepare for the assumption of financial risk under the KCC Model.

The KCE will publicly disclose on this website additional arrangements that qualify for the KCC Implementation Period Waivers as they are authorized by its governing board, in compliance with public disclosure requirements.

Company

Fresenius Medical Care Holdings, Inc.
Fresenius Seamless Care
PO Box 162970
Austin, TX 78716-2970

Governing Body

Metrolina Nephrology Associates, George Hart, MD
Fresenius Health Partners, Maritza Izquierdo
Independent Consumer Advocate, William Howe